Cyclopentenyl cytosine: interspecies predictions based on rodent plasma and urine kinetics.
A hybrid compartmental-physiological model for cyclopentenyl cytosine (CPE-C) is designed on the basis of early limited rodent pharmacokinetic data. Application of model independent pharmacokinetics and biochemical knowledge was first used to conceptualize such a model. The approach was to scale the physiological parameters of the model (compartmental clearances) and keep constant the anatomic parameters of the model (compartment volumes). Scaling of physiological mechanisms was based on body weight/surface area ratios. Using these principles, simulations with the model can reasonably anticipate the in vivo behavior of (CPE-C) in several species (mouse, rat, dog). The model is useful in understanding species differences in pharmacokinetic behavior of CPE-C.
Zaharko
D S
DS
Pharmacology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Kelley
J A
JA
Tomaszewski
J E
JE
Hegedus
L
L
Hartman
N R
NR
D000818:Animals; D000970:Antineoplastic Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine; D003198:Computer Simulation; D003562:Cytidine / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics / Q000652:urine; D004285:Dogs; D004334:Drug Administration Schedule; D007275:Injections, Intravenous; D051379:Mice; D008954:Models, Biological; D051381:Rats; D013045:Species Specificity
D000970:Antineoplastic Agents; D003562:Cytidine; C045911:cyclopentenyl cytosine